- Home
- ASTC vs PYPD Comparison
ASTC vs PYPD Comparison
Compare ASTC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- PYPD
- Stock Information
- Founded
- ASTC 1984
- PYPD 2008
- Country
- ASTC United States
- PYPD Israel
- Employees
- ASTC N/A
- PYPD N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- PYPD Medical/Dental Instruments
- Sector
- ASTC Industrials
- PYPD Health Care
- Exchange
- ASTC Nasdaq
- PYPD Nasdaq
- Market Cap
- ASTC 13.6M
- PYPD 16.3M
- IPO Year
- ASTC 1995
- PYPD 2020
- Fundamental
- Price
- ASTC $8.40
- PYPD $3.41
- Analyst Decision
- ASTC
- PYPD Buy
- Analyst Count
- ASTC 0
- PYPD 2
- Target Price
- ASTC N/A
- PYPD $12.00
- AVG Volume (30 Days)
- ASTC 13.3K
- PYPD 4.5K
- Earning Date
- ASTC 11-11-2024
- PYPD 11-06-2024
- Dividend Yield
- ASTC N/A
- PYPD N/A
- EPS Growth
- ASTC N/A
- PYPD N/A
- EPS
- ASTC N/A
- PYPD N/A
- Revenue
- ASTC $1,664,000.00
- PYPD N/A
- Revenue This Year
- ASTC N/A
- PYPD N/A
- Revenue Next Year
- ASTC N/A
- PYPD N/A
- P/E Ratio
- ASTC N/A
- PYPD N/A
- Revenue Growth
- ASTC 121.87
- PYPD N/A
- 52 Week Low
- ASTC $7.00
- PYPD $2.95
- 52 Week High
- ASTC $12.29
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- ASTC 48.19
- PYPD 50.62
- Support Level
- ASTC $7.83
- PYPD $3.31
- Resistance Level
- ASTC $8.43
- PYPD $3.62
- Average True Range (ATR)
- ASTC 0.31
- PYPD 0.17
- MACD
- ASTC 0.09
- PYPD 0.01
- Stochastic Oscillator
- ASTC 95.82
- PYPD 51.25
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.